CreOsso, LLC. seeks to leverage close to 10 years of research into the effects of local delivery of insulin and insulin-mimetics on bone regeneration in long bones, extremities and the spine.

While there are many bone graft substitutes currently available, a safe, effective replacement/adjunct for autologous bone graft in fractures, non-unions and fusions is still an unmet need in orthopedics. CreOsso seeks to deliver products that address this need in a reliable, cost effective manner.